Title:
The medicine constituent containing an amorphous hybrid nanoparticle with at least one sort of protein-kinases inhibitor, and at least one sort of stable polymer stabilization matrix formation ingredients
Document Type and Number:
Japanese Patent JP6238311
Kind Code:
B2
Abstract:
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.
Inventors:
Brisander, Magnus
Demilbuquel, Mustafa
Yeson, Gerald
Malmsten, Martin
Deland, Helene
Demilbuquel, Mustafa
Yeson, Gerald
Malmsten, Martin
Deland, Helene
Application Number:
JP2014552154A
Publication Date:
November 29, 2017
Filing Date:
January 11, 2013
Export Citation:
Assignee:
XSpray Pharma AB(publ)
International Classes:
A61K31/506; A61K9/51; A61K47/34; A61P35/00; A61P35/02; A61P43/00; B01F23/00
Domestic Patent References:
| JP2010509289A | ||||
| JP2009543797A |
Attorney, Agent or Firm:
Patent business corporation Kita Aoyama International